Pilot study on sentinel node biopsy in breast cancer

Shigeru Imoto, Hiroyoshi Fukukita, Kohji Murakami, Hiroshi Ikeda, Noriyuki Moriyama

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background and Objectives: Sentinel node biopsy (SNB) in breast cancer using indigo carmine was started in January 1998, and this method has proved feasible and reliable. From our initial experience, sentinel lymph nodes (SLNs) were identified in 65 of 88 cases of breast cancer (74%). Methods: Lymphatic mapping in breast cancer was assessed using radionuclide, technetium-99m human serum albumin or technetium-99m tin colloid. A pilot study on SNB with dye or a combined method was performed between August 1998 and January 1999. Results: SLNs were identified in 55 of 59 cases (93%). False-negative SLNs were found in 2 cases. The sensitivity and accuracy in all cases were 92% and 96%. SLNs in 52 cases were also diagnosed by immediate frozen sectioning. The sensitivity and accuracy were 89% and 96%. Conclusions: SNB in the combined method was the best way to identify SLNs in breast cancer. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish
Pages (from-to)130-133
Number of pages4
JournalJournal of Surgical Oncology
Volume73
Issue number3
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Breast Neoplasms
Biopsy
Technetium
Indigo Carmine
Serum Albumin
Radioisotopes
Coloring Agents
cyhalothrin
Sentinel Lymph Node

Keywords

  • Breast cancer
  • Indigo carmine
  • Lymphatic mapping
  • Sentinel lymph nodes
  • Sentinel node biopsy

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Pilot study on sentinel node biopsy in breast cancer. / Imoto, Shigeru; Fukukita, Hiroyoshi; Murakami, Kohji; Ikeda, Hiroshi; Moriyama, Noriyuki.

In: Journal of Surgical Oncology, Vol. 73, No. 3, 2000, p. 130-133.

Research output: Contribution to journalArticle

Imoto, Shigeru ; Fukukita, Hiroyoshi ; Murakami, Kohji ; Ikeda, Hiroshi ; Moriyama, Noriyuki. / Pilot study on sentinel node biopsy in breast cancer. In: Journal of Surgical Oncology. 2000 ; Vol. 73, No. 3. pp. 130-133.
@article{25025f5cdfbd49c9addf779e38fb4c37,
title = "Pilot study on sentinel node biopsy in breast cancer",
abstract = "Background and Objectives: Sentinel node biopsy (SNB) in breast cancer using indigo carmine was started in January 1998, and this method has proved feasible and reliable. From our initial experience, sentinel lymph nodes (SLNs) were identified in 65 of 88 cases of breast cancer (74{\%}). Methods: Lymphatic mapping in breast cancer was assessed using radionuclide, technetium-99m human serum albumin or technetium-99m tin colloid. A pilot study on SNB with dye or a combined method was performed between August 1998 and January 1999. Results: SLNs were identified in 55 of 59 cases (93{\%}). False-negative SLNs were found in 2 cases. The sensitivity and accuracy in all cases were 92{\%} and 96{\%}. SLNs in 52 cases were also diagnosed by immediate frozen sectioning. The sensitivity and accuracy were 89{\%} and 96{\%}. Conclusions: SNB in the combined method was the best way to identify SLNs in breast cancer. (C) 2000 Wiley-Liss, Inc.",
keywords = "Breast cancer, Indigo carmine, Lymphatic mapping, Sentinel lymph nodes, Sentinel node biopsy",
author = "Shigeru Imoto and Hiroyoshi Fukukita and Kohji Murakami and Hiroshi Ikeda and Noriyuki Moriyama",
year = "2000",
doi = "10.1002/(SICI)1096-9098(200003)73:3<130::AID-JSO2>3.0.CO;2-X",
language = "English",
volume = "73",
pages = "130--133",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Pilot study on sentinel node biopsy in breast cancer

AU - Imoto, Shigeru

AU - Fukukita, Hiroyoshi

AU - Murakami, Kohji

AU - Ikeda, Hiroshi

AU - Moriyama, Noriyuki

PY - 2000

Y1 - 2000

N2 - Background and Objectives: Sentinel node biopsy (SNB) in breast cancer using indigo carmine was started in January 1998, and this method has proved feasible and reliable. From our initial experience, sentinel lymph nodes (SLNs) were identified in 65 of 88 cases of breast cancer (74%). Methods: Lymphatic mapping in breast cancer was assessed using radionuclide, technetium-99m human serum albumin or technetium-99m tin colloid. A pilot study on SNB with dye or a combined method was performed between August 1998 and January 1999. Results: SLNs were identified in 55 of 59 cases (93%). False-negative SLNs were found in 2 cases. The sensitivity and accuracy in all cases were 92% and 96%. SLNs in 52 cases were also diagnosed by immediate frozen sectioning. The sensitivity and accuracy were 89% and 96%. Conclusions: SNB in the combined method was the best way to identify SLNs in breast cancer. (C) 2000 Wiley-Liss, Inc.

AB - Background and Objectives: Sentinel node biopsy (SNB) in breast cancer using indigo carmine was started in January 1998, and this method has proved feasible and reliable. From our initial experience, sentinel lymph nodes (SLNs) were identified in 65 of 88 cases of breast cancer (74%). Methods: Lymphatic mapping in breast cancer was assessed using radionuclide, technetium-99m human serum albumin or technetium-99m tin colloid. A pilot study on SNB with dye or a combined method was performed between August 1998 and January 1999. Results: SLNs were identified in 55 of 59 cases (93%). False-negative SLNs were found in 2 cases. The sensitivity and accuracy in all cases were 92% and 96%. SLNs in 52 cases were also diagnosed by immediate frozen sectioning. The sensitivity and accuracy were 89% and 96%. Conclusions: SNB in the combined method was the best way to identify SLNs in breast cancer. (C) 2000 Wiley-Liss, Inc.

KW - Breast cancer

KW - Indigo carmine

KW - Lymphatic mapping

KW - Sentinel lymph nodes

KW - Sentinel node biopsy

UR - http://www.scopus.com/inward/record.url?scp=0034104961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034104961&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9098(200003)73:3<130::AID-JSO2>3.0.CO;2-X

DO - 10.1002/(SICI)1096-9098(200003)73:3<130::AID-JSO2>3.0.CO;2-X

M3 - Article

C2 - 10738263

AN - SCOPUS:0034104961

VL - 73

SP - 130

EP - 133

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -